These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29115999)

  • 1. Screening a protein kinase inhibitor library against Plasmodium falciparum.
    Hallyburton I; Grimaldi R; Woodland A; Baragaña B; Luksch T; Spinks D; James D; Leroy D; Waterson D; Fairlamb AH; Wyatt PG; Gilbert IH; Frearson JA
    Malar J; 2017 Nov; 16(1):446. PubMed ID: 29115999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
    Crowther GJ; Hillesland HK; Keyloun KR; Reid MC; Lafuente-Monasterio MJ; Ghidelli-Disse S; Leonard SE; He P; Jones JC; Krahn MM; Mo JS; Dasari KS; Fox AM; Boesche M; El Bakkouri M; Rivas KL; Leroy D; Hui R; Drewes G; Maly DJ; Van Voorhis WC; Ojo KK
    PLoS One; 2016; 11(3):e0149996. PubMed ID: 26934697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage Activity.
    Lima MNN; Borba JVB; Cassiano GC; Mottin M; Mendonça SS; Silva AC; Tomaz KCP; Calit J; Bargieri DY; Costa FTM; Andrade CH
    ChemMedChem; 2021 Apr; 16(7):1093-1103. PubMed ID: 33247522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials.
    van der Watt ME; Reader J; Churchyard A; Nondaba SH; Lauterbach SB; Niemand J; Abayomi S; van Biljon RA; Connacher JI; van Wyk RDJ; Le Manach C; Paquet T; González Cabrera D; Brunschwig C; Theron A; Lozano-Arias S; Rodrigues JFI; Herreros E; Leroy D; Duffy J; Street LJ; Chibale K; Mancama D; Coetzer TL; Birkholtz LM
    J Antimicrob Chemother; 2018 May; 73(5):1279-1290. PubMed ID: 29420756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.
    Ansell KH; Jones HM; Whalley D; Hearn A; Taylor DL; Patin EC; Chapman TM; Osborne SA; Wallace C; Birchall K; Large J; Bouloc N; Smiljanic-Hurley E; Clough B; Moon RW; Green JL; Holder AA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6032-43. PubMed ID: 25070106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viability Screen of LOPAC
    Tong JX; Ang SEL; Tan EHN; Tan KSW
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum protein kinase as a potential therapeutic target for antimalarial drugs development.
    Mahmud F; Lee PC; Abdul Wahab H; Mustaffa KMF; Leow CH; Azhar R; Lai NS
    Trop Biomed; 2020 Sep; 37(3):822-841. PubMed ID: 33612795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
    Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
    Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
    Chapman TM; Osborne SA; Bouloc N; Large JM; Wallace C; Birchall K; Ansell KH; Jones HM; Taylor D; Clough B; Green JL; Holder AA
    Bioorg Med Chem Lett; 2013 May; 23(10):3064-9. PubMed ID: 23570789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
    Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical interrogation of the malaria kinome.
    Derbyshire ER; Zuzarte-Luís V; Magalhães AD; Kato N; Sanschagrin PC; Wang J; Zhou W; Miduturu CV; Mazitschek R; Sliz P; Mota MM; Gray NS; Clardy J
    Chembiochem; 2014 Sep; 15(13):1920-30. PubMed ID: 25111632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum.
    Avery VM; Bashyam S; Burrows JN; Duffy S; Papadatos G; Puthukkuti S; Sambandan Y; Singh S; Spangenberg T; Waterson D; Willis P
    Malar J; 2014 May; 13():190. PubMed ID: 24886460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.
    Sharma V; Agarwal S; Madurkar SM; Datta G; Dangi P; Dandugudumula R; Sen S; Singh S
    Malar J; 2014 Nov; 13():467. PubMed ID: 25431142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
    Lucumi E; Darling C; Jo H; Napper AD; Chandramohanadas R; Fisher N; Shone AE; Jing H; Ward SA; Biagini GA; DeGrado WF; Diamond SL; Greenbaum DC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3597-604. PubMed ID: 20547797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation.
    Mehta N; Ferrins L; Leed SE; Sciotti RJ; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):577-591. PubMed ID: 29301082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agents.
    Huang W; Hulverson MA; Zhang Z; Choi R; Hart KJ; Kennedy M; Vidadala RSR; Maly DJ; Van Voorhis WC; Lindner SE; Fan E; Ojo KK
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5487-5491. PubMed ID: 27780638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.